Research Articles

Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3
stats4

Search for:

     Symbiotic
38 records.
Article ID PMID Source Title Publish Year
A00851 34948020 Int J Mol Sci The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. 2021 Details
A02001 34533882 Cancer Sci Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. 2021 Details
A02284 34437908 J Hepatol Intestinal virome and therapeutic potential of bacteriophages in liver disease. 2021 Details
A02892 34204274 Int J Mol Sci Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. 2021 Details
A03766 33871224 Minerva Gastroenterol (Torino) Gut microbiota and non-alcoholic fatty liver disease. 2021 Details
A04600 33567710 Int J Environ Res Public Health Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date. 2021 Details
A11983 30658519 Int J Mol Sci Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. 2019 Details
A12117 32864300 Curr Pharmacol Rep Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health. 2019 Details
A12159 30578461 Adv Exp Med Biol Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT). 2019 Details
A13150 30113661 Nutr Rev Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. 2018 Details
A13994 29653359 J Nutr Biochem The role of the gut microbiota in the pathology and prevention of liver disease. 2018 Details
A15228 29035308 Nutrients Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. 2017 Details
A15259 29019564 Arq Bras Cir Dig THE IMPACT OF THE USE OF SYMBIOTICS IN THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN A RAT MODEL. 2018 Details
A15422 28921469 Adv Exp Med Biol Microbial Factors in Inflammatory Diseases and Cancers. 2017 Details
A16203 28507473 EXCLI J Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease. 2017 Details
A16677 28250783 J Res Med Sci Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial. 2016 Details
A17235 27895587 Front Physiol Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models. 2016 Details
A17278 27866836 Cell Metab Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP. 2016 Details
A18516 27076897 Int J Prev Med The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical Trial. 2016 Details
A18632 27023533 Int J Mol Sci Gut Microbiota and Lifestyle Interventions in NAFLD. 2016 Details
A19521 26512643 Int J Mol Sci Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. 2015 Details
A20121 26140087 World J Hepatol Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. 2015 Details
A21226 25469019 World J Gastroenterol Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. 2014 Details
A22590 24440671 Gastroenterology Interactions between the intestinal microbiome and liver diseases. 2014 Details
A27960 16895997 Proc Natl Acad Sci U S A Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. 2006 Details
A32188 29029003 Environ Entomol Rearing Xyleborus volvulus (Coleoptera: Curculionidae) on Media Containing Sawdust from Avocado or Silkbay, With or Without Raffaelea lauricola (Ophiostomatales: Ophiostomataceae). 2017 Details
A37074 16527458 Neural Netw Symbiotic adaptive neuro-evolution applied to rainfall-runoff modelling in northern England. 2006 Details
A37105 16468576 IEEE Trans Syst Man Cybern B Cybern A study of evolutionary multiagent models based on symbiosis. 2006 Details
A42289 34964947 J Microbiol The human symbiont Bacteroides thetaiotaomicron promotes diet-induced obesity by regulating host lipid metabolism. 2021 Details
A42388 34698580 Crit Rev Food Sci Nutr Effect of kombucha intake on the gut microbiota and obesity-related comorbidities: A systematic review. 2021 Details
A42980 32895142 Nan Fang Yi Ke Da Xue Xue Bao [Gut microbiota-an important contributor to liver diseases]. 2020 Details
A45621 23610585 Hepat Mon Probiotic as a novel treatment strategy against liver disease. 2013 Details
A48996 21995448 Microb Cell Fact Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. 2011 Details
A50292 35442322 Arq Gastroenterol PROBIOTIC, PREBIOTIC OR SYMBIOTIC SUPPLEMENTATION IMPACTS ON INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW. 2022 Details
A50320 35434600 Food Chem X Kombucha - An ancient fermented beverage with desired bioactivities: A narrowed review. 2022 Details
A51142 35511325 J Microbiol Host-microbial interactions in metabolic diseases: from diet to immunity. 2022 Details
A51811 33953584 Diabetes Metab Syndr Obes Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System. 2021 Details
A52398 27633133 Endocrinol Nutr An update on probiotics, prebiotics and symbiotics in clinical nutrition. 2016 Details